# Mangalam Drugs & Organics Ltd (MANGALAM)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹29.41
Day Change: -3.61%
52W High: ₹116
52W Low: ₹22.7
Market Cap: ₹48 Cr

## Valuation
P/E: 0
P/B: 0.37
EPS: ₹-19.53
Book Value: ₹80.58
Dividend Yield: 0%

## Returns
1Y Return: -51.47%

## Profitability
ROE: 0%
ROCE: 8.6%
Debt/Equity: 0.8
Revenue Growth: -34.1%
Profit Growth: 0%
EBITDA Margin: 1.42%
Operating Margin: -10.09%

## About
Mangalam Drugs & Organics Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Mangalam Drugs & Organics Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Change in Management
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Data Freshness
Quote Updated: 2026-05-24T20:00:13.396Z
Price History Updated: 2026-05-19T01:02:40.353Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-19T01:02:40.353Z
Quant Updated: 2026-05-19T01:02:40.353Z
Sentiment Updated: 2026-05-19T01:02:40.353Z
Financials Status: current
Financials Updated: 2026-05-18T23:08:35.976Z
Financials Last Attempt: 2026-05-18T23:08:35.976Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2025)
Revenue: ₹369 Cr
Operating Profit: ₹17 Cr (OPM 5%)
Net Profit: ₹-9 Cr
Tax: ₹-11 Cr

## Annual P&L History
Mar 2025: Rev ₹369Cr | PAT ₹-9Cr | OPM 5%
Mar 2026: Rev ₹318Cr | PAT ₹7Cr | OPM 11%

## Balance Sheet (Mar 2025)
Total Assets: ₹334 Cr
Total Liabilities: ₹334 Cr
Borrowings: ₹107 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Govardhan Murlidhar Dhoot, Chairman & MD
- Brijmohan Murlidhar Dhoot, Whole-Time Director
- Kamal Ishvarlal Vashi, President
- Jeevan Mukund Dalvi, Chief Financial Officer
- Krishnapriya  Nawal, Chief Operating Officer

---
Source: rupiya.io/stocks/mangalam
Disclaimer: For research and education only. Not investment advice.